Antioxidant supplement use after breast cancer diagnosis and mortality in the Life after Cancer Epidemiology (LACE) cohort

Cancer

Volumn 118, Issue 8, 2012, Pages 2048-2058

  Greenlee, Heather ^a,b,c   Kwan, Marilyn L ^d   Kushi, Lawrence H ^d   Song, Jun ^d   Castillo, Adrienne ^d   Weltzien, Erin ^d   Quesenberry Jr , Charles P ^d   Caan, Bette J ^d  

^a Department of Medicine   (United States)

^b Kaiser Permanente Northern California ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

antioxidants; breast cancer; dietary supplements; epidemiology; mortality

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; LYCOPENE; MULTIVITAMIN; SELENIUM;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK REDUCTION;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BREAST NEOPLASMS; CAROTENOIDS; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME; VITAMIN E;

EID: 84859628264     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26526     Document Type: Article

References (21)

1. Velicer CM, Ulrich CM,. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008; 26: 665-673.
2. Greenlee H, Hershman DL, Jacobson JS,. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat. 2009; 115: 437-452.
3. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB,. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008; 100: 773-783.
4. Hoffer A, Pauling L,. Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving those doses. J Orthomolecular Med. 1990; 5: 143-154.
5. Hoffer A, Pauling L,. Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses. J Orthomolecular Med. 1993; 8: 157-167.
6. Fleischauer AT, Simonsen N, Arab L,. Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr Cancer. 2003; 46: 15-22.
7. Lockwood K, Moesgaard S, Folkers K,. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun. 1994; 199: 1504-1508.
8. Poulter JM, White WF, Dickerson JW,. Ascorbic acid supplementation and 5 year survival rates in women with early breast cancer. Acta Vitaminol Enzymol. 1984; 6: 175-182.
9. Nechuta S, Lu W, Chen Z, et al. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2011; 20: 262-271.
10. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML,. Life After Cancer Epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005; 16: 545-556.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
12. Psaty BM, Koepsell TD, Siscovick D, et al. An approach to several problems in using large databases for population-based case-control studies of the therapeutic efficacy and safety of anti-hypertensive medicines. Stat Med. 1991; 10: 653-662.
13. D'Andrea GM,. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005; 55: 319-321.
14. Labriola D, Livingston R,. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park). 1999; 13: 1003-1008; discussion 1008, 1011-1002.
15. Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005; 23: 5805-5813.
16. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 2005; 97: 481-488.
17. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003; 290: 476-485.
18. Goodman GE, Thornquist MD, Balmes J, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst. 2004; 96: 1743-1750.
19. Kwan ML, Greenlee H, Lee VS, et al. Multivitamin use and breast cancer outcomes in women with early stage breast cancer: the Life After Cancer Epidemiology study [published online ahead of print May 11, 2011]. Breast Cancer Res. Treat. 2011.
20. Greenlee H, Gammon MD, Abrahamson PE, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer. 2009; 115: 3271-3282.
21. Greenlee H, Kwan ML, Ergas IJ, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009; 117: 653-665.